| MREFX | TRZPX | MREFX / TRZPX | |
| Total Expense Ratio | 1.40 | 0.00 | - |
| Annual Report Gross Expense Ratio | 1.92 | 0.84 | 229% |
| Fund Existence | 23 years | 5 years | - |
| Gain YTD | 9.552 | 21.551 | 44% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 114M | 926M | 12% |
| Annual Yield % from dividends | 2.39 | 3.06 | 78% |
| Returns for 1 year | 9.29 | 15.87 | 59% |
| Returns for 3 years | 41.00 | 40.85 | 100% |
| Returns for 5 years | 35.25 | N/A | - |
| Returns for 10 years | 58.09 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JFNCX | 67.90 | 0.61 | +0.91% |
| Janus Henderson Global Life Sciences C | |||
| MEQAX | 11.49 | 0.09 | +0.79% |
| American Century International Val A | |||
| KSOCX | 153.98 | 0.56 | +0.37% |
| Kinetics Small Cap Opportunities Adv C | |||
| ABIEX | 10.26 | 0.01 | +0.10% |
| AB Emerging Markets Multi-Asset I | |||
| PQUAX | 12.91 | 0.01 | +0.08% |
| PACE Small/Medium Co Growth Equity A | |||